Optimization of Rituximab for the Treatment of Diffuse Large B-Cell Lymphoma (II): Extended Rituximab Exposure Time in the SMARTE-R-CHOP-14 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group

Journal of Clinical Oncology - United States
doi 10.1200/jco.2013.54.6861
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

A Multicentre Study of Primary Breast Diffuse Large B-Cell Lymphoma in the Rituximab Era

British Journal of Haematology
Hematology
2014English

The Rituximab Maintenance Therapy Improves Prognosis of Transformed Diffuse Large B Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Rituximab in the Treatment of B-Cell Non-Hodgkin Lymphoma, Focus on Outcomes and Comparative Effectiveness

ClinicoEconomics and Outcomes Research
Health PolicyEconomicsEconometricsFinance
2010English

A Phase Ii Study of Lenalidomide and Rituximab (R²) Combination in Patients With High-Risk Refractory/Relapsed Diffuse Large B-Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Regulation of CD20 in Rituximab-Resistant Cell Lines and B-Cell Non-Hodgkin Lymphoma

Clinical Cancer Research
Cancer ResearchOncology
2012English

Subcutaneous Rituximab in B-Cell Non-Hodgkin Lymphoma: A Single-Center Experience

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

The Kyoto Prognostic Index for Patients With Diffuse Large B-Cell Lymphoma in the Rituximab Era

Blood
BiochemistryImmunologyCell BiologyHematology
2015English

Sandoz Rituximab for Treatment of Diffuse Large B-Cell Lymphoma: Interim Safety Results of the Non-Interventional, Observational, Multicenter, Open-Label Reflect Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Rituximab and Autologous Stem-Cell Transplantation for High-Risk Diffuse Large B-Cell Lymphoma – Authors' Reply

The Lancet Oncology
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy